Cargando…
Severe immune thrombocytopenia following COVID-19 vaccination (Moderna) and immune checkpoint inhibitor
Safe and effective prophylactic vaccines are urgently needed to contain the coronavirus disease 2019 (COVID-19) pandemic. However, several vaccination-related adverse effects have been reported. Here, we report a rare case of severe immune thrombocytopenia occurring 3 days after receiving the mRNA-1...
Autores principales: | Chong, Kah-Meng, Yang, Ching-Yao, Lin, Chien-Chin, Lien, Wan-Ching |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932008/ https://www.ncbi.nlm.nih.gov/pubmed/35339338 http://dx.doi.org/10.1016/j.ajem.2022.03.030 |
Ejemplares similares
-
Immune Thrombocytopenia Following Booster Dose of the Moderna mRNA-1273 Vaccine
por: Breetz, Katherine A, et al.
Publicado: (2022) -
Severe immune thrombocytopenia following COVID-19 vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2022) -
Hematological Side Effects of Immune Checkpoint Inhibitors: The Example of Immune-Related Thrombocytopenia
por: Calvo, Roser
Publicado: (2019) -
Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy
por: Shiuan, Eileen, et al.
Publicado: (2017) -
Immune Thrombocytopenia Induced by Immune Checkpoint Inhibitors in Solid Cancer: Case Report and Literature Review
por: Liu, Xiaolin, et al.
Publicado: (2020)